The easiest way to email your members of Congress
Donate Now
You are writing regarding
0% of users oppose S.1734
S.1734 has been viewed 1,429 times
S.1734 Generating Antibiotic Incentives Now Act of 2011, 112th Congress
Sponsor: Sen. Richard Blumenthal [D, CT]Contact Congress
1.
Choose Your Position
2.
Write Your Letter
3.
Share Your Communication
OpenCongress Message Builder
OpenCongress Message Builder
Use the tools in this column to help craft your letter. Anytime your mouse highlights a section, click on it to add prepared text. You can edit any part of the message at left, and if you like, add your own stories and text to personalize your letter.
Official Bill Info
-
Latest Action: Oct 19, 2011
Introduced in Senate
Clicking this will add the following text:
I know the most recent action for this bill is as follows: "Introduced in Senate" on Oct 19, 2011 -
Committee Assignment:
Senate Health, Education, Labor, and Pensions
Clicking this will add the following text:
This bill has been assigned to the Senate Health, Education, Labor, and Pensions committee.
Bill Statistics on OpenCongress
Clicking this will add the following text:
0% of users on OpenCongress.org, a free, non-partisan resource, oppose S.1734.
Clicking this will add the following text:
S.1734 has been viewed 1,429 times on OpenCongress.org, a free, non-partisan resource.
Contribution Data
Enter your street address above, and relevant campaign contribution data for your elected officials will appear here in seconds for you to use in your letter.
Most-commented sections of the bill text
Highest Rated User Comments
Highly Rated Blog Articles
-
Legislative Update for 16 March 2012: “Keeping Faith”? Not So ...
-
March 26, 2012
by
Gene Fenstermacher
-
H.R. 2182 and S. 1734 (Rep. Phil Gingrey, R-GA and Sen. Richard Blumenthal, D-CT): Companion House and Senate bills would provide incentives to increase the commercial value of innovative antibiotic drugs and ...
Clicking this will add the following text:
As noted by Gene Fenstermacher on March 26, 2012, "H.R. 2182 and S. 1734 (Rep. Phil Gingrey, R-GA and Sen. Richard Blumenthal, D-CT): Companion House and Senate bills would provide incentives to increase the commercial value of innovative antibiotic drugs and ..." (/url?q=http://moaacoronado.org/%3Fp%3D615&sa=U&ei=ICdzT_jgN8XY2AW1x8TtDg&ved=0CDcQmAEwBA&usg=AFQjCNEVzpkTofyIWL13BEWIC2bxTrJhaA) -
Legislative Update for 16 March 2012: “Keeping Faith”? Not So ...
-
March 26, 2012
by
Gene Fenstermacher
-
H.R. 2182 and S. 1734 (Rep. Phil Gingrey, R-GA and Sen. Richard Blumenthal, D-CT): Companion House and Senate bills would provide incentives to increase the commercial value of innovative antibiotic drugs and ...
Clicking this will add the following text:
As noted by Gene Fenstermacher on March 26, 2012, "H.R. 2182 and S. 1734 (Rep. Phil Gingrey, R-GA and Sen. Richard Blumenthal, D-CT): Companion House and Senate bills would provide incentives to increase the commercial value of innovative antibiotic drugs and ..." (/url?q=http://moaacoronado.org/%3Fp%3D615&sa=U&ei=rM9xT47IIubK2AXFiqzXDg&ved=0CC4QmAEwAg&usg=AFQjCNFHeZHLaGa3xfeEQ3LyhnRNKXDI0A) -
Legislative Update for 16 March 2012: “Keeping Faith”? Not So ...
-
March 25, 2012
by
Gene Fenstermacher
-
H.R. 2182 and S. 1734 (Rep. Phil Gingrey, R-GA and Sen. Richard Blumenthal, D-CT): Companion House and Senate bills would provide incentives to increase the commercial value of innovative antibiotic drugs and ...
Clicking this will add the following text:
As noted by Gene Fenstermacher on March 25, 2012, "H.R. 2182 and S. 1734 (Rep. Phil Gingrey, R-GA and Sen. Richard Blumenthal, D-CT): Companion House and Senate bills would provide incentives to increase the commercial value of innovative antibiotic drugs and ..." (/url?q=http://moaacoronado.org/%3Fp%3D615&sa=U&ei=Do1wT63nHqXm2QX67snyAQ&ved=0CC4QmAEwAg&usg=AFQjCNEHEwZwQ4lXYcxw6DPanHjfzbKjQw)
Highly Rated News Articles
-
Vivaldi on the Lawn
-
July 21, 2012
by
Weekly Standard
-
In anticipation of this month’s Summer Olympics, one of the cleverest cultural events of the Jubilee weekend was the world premiere at Garsington Opera of the critical edition of Antonio Vivaldi’s 1734 opera L’Olimpiade, which combines romantic ...
Clicking this will add the following text:
As noted by Weekly Standard on July 21, 2012, "In anticipation of this month’s Summer Olympics, one of the cleverest cultural events of the Jubilee weekend was the world premiere at Garsington Opera of the critical edition of Antonio Vivaldi’s 1734 opera L’Olimpiade, which combines romantic ..." (http://www.weeklystandard.com/articles/vivaldi-lawn_648823.html) -
Credit Suisse (Eur) Form 8.5 (EPT/NON-RI) - Xstrata Plc
-
July 18, 2012
by
Bloomberg
-
Credit Suisse (Eur) - Form 8.5 (EPT/NON-RI) - Xstrata Plc RNS Number : 9472H Credit Suisse Securities (Eur) Ltd 18 July 2012 FORM 8.5 (EPT/NON-RI) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER ...
Clicking this will add the following text:
As noted by Bloomberg on July 18, 2012, "Credit Suisse (Eur) - Form 8.5 (EPT/NON-RI) - Xstrata Plc RNS Number : 9472H Credit Suisse Securities (Eur) Ltd 18 July 2012 FORM 8.5 (EPT/NON-RI) PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER ..." (http://www.bloomberg.com/article/2012-07-18/aMvi1P3ARhiM.html) -
Corker Praises Passage Of GAIN Act In FDA User Fee Reauthorization Bill
-
May 24, 2012
by
Chattanoogan
-
U.S. Senators Bob Corker and Richard Blumenthal (D-CT) and U.S. Representative Phil Gingrey, M.D., (R-GA) Thursday praised Senate passage of the GAIN Act (S.1734) as part of the Food and Drug Administration User Fee Reauthorization bill. The ...
Clicking this will add the following text:
As noted by Chattanoogan on May 24, 2012, "U.S. Senators Bob Corker and Richard Blumenthal (D-CT) and U.S. Representative Phil Gingrey, M.D., (R-GA) Thursday praised Senate passage of the GAIN Act (S.1734) as part of the Food and Drug Administration User Fee Reauthorization bill. The ..." (http://www.chattanoogan.com/2012/5/24/226895/Corker-Praises-Passage-Of-GAIN-Act-In.aspx)
We are trying to send your message

Contact Congress




